“Valve‐in‐valve” for the treatment of paravalvular leaks following transcatheter aortic valve implantation

Transcatheter aortic valve implantation (TAVI) is commonly associated with some degree of aortic regurgitation (AR) secondary to the presence of paravalvular leaks. We present the case of an 86‐year‐old woman diagnosed with severe aortic stenosis who underwent TAVI with a 23‐mm Edwards‐SAPIEN valve. The procedure complicated with a severe paravalvular leak following TAVI that was unresponsive to balloon postdilation. This complication was successfully managed with the implantation of a second valve of the same diameter within the first one (“valve‐in‐valve”) resulting in trivial residual AR and the absence of significant transvalvular gradient at the end of the procedure. © 2009 Wiley‐Liss, Inc.

[1]  Philippe Pibarot,et al.  Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. , 2009, Journal of the American College of Cardiology.

[2]  C. Tamburino,et al.  The valve‐in‐valve technique: Transcatheter treatment of aortic bioprothesis malposition , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  Jeroen J. Bax,et al.  Percutaneous valve-in-valve procedure for severe paravalvular regurgitation in aortic bioprosthesis. , 2009, JACC. Cardiovascular imaging.

[4]  Philippe Pibarot,et al.  Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. , 2009, The Annals of thoracic surgery.

[5]  M. Cheitlin.  United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex , 2009 .

[6]  P. Pibarot,et al.  Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. , 2008, The American journal of cardiology.

[7]  C. Ruiz,et al.  First percutaneous transcatheter aortic valve‐in‐valve implant with three year follow‐up , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  Ghassan Sleilaty,et al.  Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. , 2008, Journal of the American College of Cardiology.

[9]  Mirko Doss,et al.  Transapical Minimally Invasive Aortic Valve Implantation: Multicenter Experience , 2007, Circulation.

[10]  Lukas Altwegg,et al.  Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.

[11]  Thomas Walther,et al.  Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.

[12]  M. Mack,et al.  Transapical minimally invasive aortic valve implantation , 2007 .

[13]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.